Praxis Precision Medicines, Inc. PRAX Preferred Stock, Shares Authorized
Preferred Stock, Shares Authorized at other companies
Other financials
Where this comes from
Reported directly by Praxis Precision Medicines, Inc. in its filing.
Tagged under the XBRL concept us-gaap:PreferredStockSharesAuthorized.
The official record: Praxis Precision Medicines, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Praxis Precision Medicines, Inc.'s preferred stock, shares authorized.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Praxis Precision Medicines, Inc.'s preferred stock, shares authorized?
- Praxis Precision Medicines, Inc. (PRAX) reported preferred stock, shares authorized of $10M in Q1 2026.
- How has Praxis Precision Medicines, Inc.'s preferred stock, shares authorized changed year-over-year?
- Praxis Precision Medicines, Inc.'s preferred stock, shares authorized decreased by 0.0% year-over-year, from $10M to $10M.
- What is the long-term trend for Praxis Precision Medicines, Inc.'s preferred stock, shares authorized?
- Over 5 years (2020 to 2025), Praxis Precision Medicines, Inc.'s preferred stock, shares authorized has grown at a 0.0% compound annual growth rate (CAGR), from $10M to $10M.